The T6SS as a search engine for naturally validated antibacterial targets

点击翻译按钮获取中文摘要

Bacterial resistance has emerged to all clinically relevant antibiotics. Despite the widespread recognition of this as a global crisis the majority of the strategies implemented thus far have been disappointingly unsuccessful, notably those based on rational drug design and target identification approaches. One fundamental and key issue is indeed to define what a good antimicrobial target is so that it would effectively be amenable to drug design. Over billions of years microbes have evolved the best ways to out-compete others to gain access to space and nutrients. They have identified bacterial Achille's heels and designed strategies to inactivate corresponding molecular pathways that would right away challenge bacterial growth and survival. This is what one can consider as naturally validated drug targets.The bacterial Type VI Secretion System (T6SS) is the ultimate weapon killing competitors by toxins injection. Most characterized T6SS toxins work against cell wall, membrane, nucleic acids, which are all classic targets for most of our current antibiotics. We are at the beginning of understanding how this system works and the characterized T6SS toxins represent only the tip of the iceberg. It is also important to realise that the bacteria that produces T6SS toxins would also produce specific immunity proteins that specifically protect against the activity of each individual T6SS toxin. One key observation is that the gene encoding the toxin and the gene encoding the immunity are found on the bacterial genome as tandem gene pairs next to each other.This project aims at exploiting the largely overlooked reservoir of natural antibacterials, namely the plethora of T6SS toxins that bacteria have evolved to effectively kill bacterial competitors and which we believe exist in a much larger number and have an unexpected broad range of diverse biochemical activity. While T6SS toxins themselves are unlikely to be effective therapeutics in the short term, the naturally validated antibacterial targets they point us towards would be of great value.A potent gram-negative bacterium using the T6SS to outcompete and kill foes is Pseudomonas aeruginosa, an organism which is high on the WHO list of pathogens that are critical for Anti-Microbial Resistance (AMR). Here, we will use P. aeruginosa as model to perform a systematic search for T6SS toxins, which are not identifiable using standard genomic and bioinformatic analysis. In previous work my laboratory implemented a genetic screen (TraDIS) to identify transposon mutants sensitive to the T6SS. These mutants are affected in distinct immunity genes and the characterization of the adjacent gene would lead to the identification of a novel T6SS toxin. Our screen was fully validated since it allowed to identify the toxin/immunity pairs which were already known and proved to be very effective at the identification of unsuspected T6SS toxins and their immunities. One of the T6SS toxin which we propose to fully characterize in the present proposal is called Tse8 and is suspected to interfere with protein synthesis, notably by hampering function of the transamidosome complex which leads to a shortage in Asn- and Gln-tRNA.Finding new toxins and determining their mechanisms of action is going to offer a gold mine of usable antibacterial targets that pharmaceutical companies would be able to consider in the future. Furthermore, understanding how bacteria fight each other in ways we might not suspect is what is needed to prepare translational impact.